HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an electronic Letter to the Editor about this paper Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Fruchon, S. Articles by Coppin, H. Search for Related Content PubMed PubMed Citation Articles by Fruchon, S. Articles by Coppin, H. Related Collections Molecular Diagnostics and Genetics

Use of Denaturing HPLC and a Heteroduplex Generator to Detect the HFE C282Y Mutation Associated with Genetic Hemochromatosis

¹ Unité de Physiopathologie Cellulaire et Moléculaire, CNRS UPR 2163, CHU Purpan, 31059 Toulouse Cedex 3, France

^aauthor for correspondence: fax 33-5-6149-9036, e-mail roth@cict.fr

The first 300 words of the full text of this article appear below.

Hereditary hemochromatosis (HH) is a common autosomal recessive disorder of iron metabolism. Most individuals with HH are homozygous for a 845GA missense mutation (C282Y) in the HFE gene that encodes a MHC class I-like protein (1)(2)(3)(4)(5). One in 300 adults of Caucasian descent has this genotype (3)(6). The disease is characterized by increased absorption of dietary iron by the gastrointestinal tract and the progressive deposition of iron in the parenchymal cells. It produces a wide range of clinical complications, including hepatic fibrosis, cirrhosis, hepatocellular carcinoma, diabetes mellitus, hypopituitarism, hypogonadism, arthritis, and cardiomyopathy (7). These complications can be entirely prevented with regular iron removal by phlebotomy. The availability of this effective treatment highlights the value of screening appropriate populations for the C282Y mutation to detect HH before irreversible complications occur (8). Another frequent mutation in the HFE gene, H63D, has been described (1), but the relationship between this mutation and iron overload is less clear. Although compound heterozygotes C282Y/H63D (1) and H63D homozygotes (9) may show some degree of iron overload, the penetrance associated with these genotypes is very low, and clinical features of hemochromatosis, especially liver disease, are rare. In opposition to C282Y, screening the population for H63D is therefore not indicated.

An important issue is the development of a cost-effective methodology suitable for genetically testing large numbers of samples for the C282Y mutation. Many methods have been used to detect C282Y, including oligonucleotide ligation assays (1), fragment length polymorphism analyses of PCR products after restriction enzyme digestion (5), allele-specific oligonucleotide hybridization assays (2), mutagenically separated PCR assays (10), primer extension assays (11)(12), . . . [Full Text of this Article]

The following articles in journals at HighWire Press have cited this article:

				H. Coppin, M Bensaid, S Fruchon, N Borot, H Blanche, and M. Roth Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians BMJ, July 17, 2003; 327(7407): 132 - 133. [Full Text] [PDF]